Background: There is increasing evidence that the presence of an ongoing systemic
inflammatory response is a stage-independent predictor of poor outcome in patients with …

Some successful chemotherapeutics, notably anthracyclines and oxaliplatin, induce a type
of cell stress and death that is immunogenic, hence converting the patient's dying cancer …

BACKGROUND: Plasmablastic lymphoma (PBL) is a rare and aggressive B‐cell lymphoma
strongly associated with human immunodeficiency virus (HIV) infection. The authors …

Although great effort is being expended in the development of cancer immunotherapies, it is
surprising that global lymphopenia and its various dimensions are not being systematically …

Background Recent research has shown a correlation between immune microenvironment
and lymphoma biology. This study aims to investigate the prognostic significance of the …

Background Data regarding the role of systemic therapy in patients with advanced well-
differentiated/dedifferentiated liposarcomas (WDLPS/DDLPS) are limited. Methods From …

Background The immune system strongly influences outcome in patients with ovarian
cancer. In particular, the absolute lymphocyte count in peripheral blood (ALC) and the …

Lymphopenia (< 1Giga/L) detected before initiation of chemotherapy is a predictive factor for
death in metastatic solid tumors. Combinatorial T cell repertoire (TCR) diversity was …

Introduction Lymphocytopenia and circulating tumor cells (CTCs) have been reported as
independent prognostic factors for overall survival (OS) in metastatic breast cancer (MBC) …

Background: The aim of this study was to assess whether the neutrophil to lymphocyte ratio
(NLR) and other laboratory markers may predict the prognosis of advanced colorectal …